Prognostic value of PET-CT after fi rst-line therapy in patients with follicular lymphoma: A pooled analysis of central scan review in three multicentre studies

The Lancet Haematology

Volumn 1, Issue 1, 2014, Pages e17-e27

  Trotman, Judith ^a   Luminari, Stefano ^b   Boussetta, Sami ^c   Versari, Annibale ^d   Dupuis, Jehan ^e   Tychyj, Christelle ^f   Marcheselli, Luigi ^b   Berriolo Riedinger, Alina ^g   Franceschetto, Antonella ^b   Julian, Anne ^h   Ricard, Fabien ⁱ   Guerra, Luca ^j   Haioun, Corinne ^k   Biasoli, Irene ^l   Tilly, Hervé ^m   Federico, Massimo ^b   Salles, Gilles ⁱ   Meignan, Michel ^k  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d S MARIA NUOVA HOSPITAL   (Italy)

^e HENRI MONDOR HOSPITAL   (France)

^f Centre Hospitalier Alpes Leman   (France)

^g CENTRE GEORGES FRANÇOIS LECLERC   (France)

^h Hôpital Perpan   (France)

ⁱ UNIVERSITÉ LYON 1   (France)

^j SAN GERARDO HOSPITAL   (Italy)

^k UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^l FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^m UNIVERSITÉ DE ROUEN   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; FLUORODEOXYGLUCOSE F 18; MITOXANTRONE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DEATH; FEMALE; FIVE POINT DEAUVILLE SCALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROGRESSION FREE SURVIVAL; SCORING SYSTEM; TREATMENT RESPONSE; VERY ELDERLY;

EID: 84922032387     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(14)70008-0     Document Type: Article

References (21)

1. Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link B K. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 2005; 23: 5019-26.
2. Tan D, Horning SJ, Hoppe RT, et al. Improvements in observed and relative surv ival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood 2013; 122: 981-87.
3. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258-65.
4. Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project. J Clin Oncol 2009; 27: 4555- 62.
5. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
6. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomograp hy for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571-78.
7. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for maligna nt lymphoma. J Clin Oncol 2007; 25: 579-86.
8. Trotman J, Fournier M, Lamy T, et al. Positron emission tomography-computed to mography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. J Clin Oncol 2011; 29: 3194-200.
9. Dupuis J, Berriolo-Riedinger A, Julian A, et al. Impact of [(18)F] fl uorodeoxyg lucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS. J Clin Oncol 2012; 30: 4317-22.
10. Luminari S, Biasoli I, Versari A, et al. The prognostic role of postinduction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL). Ann Oncol 2014; 25: 442-47.
11. Meignan M, Gallamini A, Meignan M, Gallamini A, Haioun C. Report on the First International Workshop on Interim-PET-Scan in Lymphoma. Leuk Lymphoma 2009; 50: 1257-60.
12. Tychyj-Pinel C, Ricard F, Fulham M, et al. PET/CT assessment in follicular ly mphoma using standardized criteria: central review in the PRIMA study. Eur J Nucl Med Mol Imaging 2014; 41: 408-15.
13. Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evalu ation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano Classifi cation. J Clin Oncol 2014; published online Aug 11. DOI:10.1200/ jco.2013.54.88002014.
14. Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the stagi ng and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014; published online Aug 11. DOI:10.1200/jco.2013.53.5229 2014.
15. Salles G, Seymour JF, Offner F, et al. Rituximab maintenance for 2 years in p atients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet 2011; 377: 42-51.
16. Federico M, Luminari S, Dondi A, et al. R-CVP versus R-CHOP versus R-FM for t he initial treatment of patients with advancedstage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi. J Clin Oncol 2013; 31: 1506-13.
17. Barosi G, Carella A, Lazzarino M, et al. Management of nodal indolent (non ma rginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation. Haematologica 2005; 90: 1236-57.
18. Luminari S, Versari A, Franceschetto A, et al. The role of qualitative FDG-PE T assessment using the 5 point Deauville scale for postinduction response assessment in patients with follicular lymphoma. a study from the Fondazione Italiana Linfomi (FIL). Blood 2013; 122: 4295.
19. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statis tic. Fam Med 2005; 37: 360-63.
20. Cabanillas F. Curability of advanced indolent or low-grade follicular lymphom as: time for a new paradigm? J Clin Oncol 2013; 31: 14-16.
21. Pyo J, Won Kim K, Jacene HA, Sakellis CG, Brown JR, Van den Abbeele AD. End-t herapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis. Clin Cancer Res 2013; 19: 6566-77.